This inventor holds 3 USPTO granted patents. Top assignee: Ocean University of China. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2026
Title: Innovations by Yaoyao Jiang
Introduction
Yaoyao Jiang is a notable inventor based in Qingdao, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with potential antitumor properties. With a total of 3 patents to his name, Jiang's work is paving the way for advancements in cancer treatment.
Latest Patents
One of Jiang's latest patents is focused on macrolide brefeldin A ester derivatives and their use in inhibiting tumor proliferation. The ester derivatives of brefeldin A, represented by Formula (I), show promise in the prevention or treatment of various hyperproliferative diseases, including liver cancer, leukemia, breast cancer, and several others. These compounds have the potential to be developed as effective antitumor agents. Another patent by Jiang details the preparation method and use of brefeldin A derivatives, further emphasizing his innovative approach to cancer therapy.
Career Highlights
Yaoyao Jiang is affiliated with the Ocean University of China, where he conducts research and develops his inventions. His work is characterized by a strong focus on creating compounds that can significantly impact the treatment of cancer and other serious diseases.
Collaborations
Jiang collaborates with esteemed colleagues, including Changlun Shao and Meiyan Wei, who contribute to his research efforts. Their combined expertise enhances the potential for groundbreaking discoveries in the field of medicinal chemistry.
Conclusion
Yaoyao Jiang's innovative work in developing antitumor agents showcases his commitment to advancing cancer treatment. His contributions are vital in the ongoing fight against various forms of cancer, and his patents reflect a promising future in medicinal research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
